Literature DB >> 3752759

Symptomatic osteoporosis in a man with hyperprolactinemic hypogonadism.

J A Jackson, M Kleerekoper, A M Parfitt.   

Abstract

A 66-year-old man presented with height loss, back pain due to an L4 vertebral compression deformity, and marked osteopenia shown by radial photon absorptiometry. The patient had small testes and a long history of infertility and impotence. Plasma testosterone was low (130 ng/dL; normal, 300 to 1000 ng/dL) with marked elevation of serum prolactin (590 ng/mL; normal, 0 to 15 ng/mL). High-resolution computed tomography showed an invasive pituitary macroadenoma with a secondary empty sella turcica. Bone histomorphometry showed low-normal trabecular bone volume with normal formation and resorption indices. The patient was treated with calcium carbonate supplements, testosterone replacement, and bromocriptine mesylate without subsequent progression of the osteoporosis. This first report of hyperprolactinemic hypogonadism in a man who presented with overt osteoporosis shows the importance of evaluating gonadal function in all osteoporotic men.

Entities:  

Mesh:

Year:  1986        PMID: 3752759     DOI: 10.7326/0003-4819-105-4-543

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  4 in total

1.  Prevalence of osteopenia in men with prolactinoma.

Authors:  E C O Naliato; M L F Farias; G R Braucks; F S R Costa; D Zylberberg; A H D Violante
Journal:  J Endocrinol Invest       Date:  2005-01       Impact factor: 4.256

2.  Prolactinoma in a middle-aged man with an osteoporotic fracture.

Authors:  S D Taylor; T M Kelly
Journal:  West J Med       Date:  1989-07

3.  Reversal of severe osteopenia in a patient with hyperprolactinemia treated with bromocriptine.

Authors:  J S Lindberg; F O Kolb; R A Blau; M R Powell
Journal:  West J Med       Date:  1988-09

4.  Case report 631: Neo-osseous porosis (metaphyseal osteopenia) in polyglandular autoimmune (Schmidt) syndrome.

Authors:  B S Vela; R I Dorin; M F Hartshorne
Journal:  Skeletal Radiol       Date:  1990       Impact factor: 2.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.